Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $24.0000 (3.36%) ($23.2300 - $24.1300) on Thu. May. 2, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.66% (three month average) | RSI | 46 | Latest Price | $24.0000(3.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -1.83% in a week (0% probabilities). VXX(-12%) VIXM(-8%) TLT(-4%) IFRA(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.83% (StdDev 3.66%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
Resistance Level | $26.29 | 5 Day Moving Average | $25.2(-4.76%) | 10 Day Moving Average | $25.91(-7.37%) | 20 Day Moving Average | $26.29(-8.71%) | To recent high | -13.5% | To recent low | 23.5% | Market Cap | $1.49b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |